These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8808869)

  • 1. Effects of estrogens only on the prostates of aging men.
    van Kesteren P; Meinhardt W; van der Valk P; Geldof A; Megens J; Gooren L
    J Urol; 1996 Oct; 156(4):1349-53. PubMed ID: 8808869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate.
    Adams JY; Leav I; Lau KM; Ho SM; Pflueger SM
    Prostate; 2002 Jun; 52(1):69-81. PubMed ID: 11992621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of chronic high dose androgen or estrogen treatment on the human prostate [corrected].
    Jin B; Turner L; Walters WA; Handelsman DJ
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4290-5. PubMed ID: 8954029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSA and PAP as immunohistochemical markers in prostate cancer.
    Epstein JI
    Urol Clin North Am; 1993 Nov; 20(4):757-70. PubMed ID: 7505984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate.
    Landry F; Chapdelaine A; Bégin LR; Chevalier S
    J Urol; 1996 Jan; 155(1):386-90. PubMed ID: 7490893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal and epithelial cells from rat ventral prostate during androgen deprivation and estrogen treatment--regulation of transcription.
    Bacher M; Rausch U; Goebel HW; Polzar B; Mannherz HG; Aumüller G
    Exp Clin Endocrinol; 1993; 101(2):78-86. PubMed ID: 8405143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate specific antigen and prostatic acid phosphatase immunoreactivity as prognostic indicators of advanced prostatic carcinoma.
    Sakai H; Yogi Y; Minami Y; Yushita Y; Kanetake H; Saito Y
    J Urol; 1993 May; 149(5):1020-3. PubMed ID: 7683340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imprinting by neonatal sex steroids on the structure and function of the mature mouse prostate.
    Singh J; Handelsman DJ
    Biol Reprod; 1999 Jul; 61(1):200-8. PubMed ID: 10377050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Androgen and estrogen metabolism in human benign prostatic hyperplasia (BPH)].
    Krieg M; Weisser H; Tunn S
    Verh Dtsch Ges Pathol; 1993; 77():19-24. PubMed ID: 7511279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that estrogens directly alter androgen-regulated prostate development.
    Jarred RA; Cancilla B; Prins GS; Thayer KA; Cunha GR; Risbridger GP
    Endocrinology; 2000 Sep; 141(9):3471-7. PubMed ID: 10965920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
    Akimoto S; Akakura K; Masai M; Isaka S; Shimazaki J
    Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional properties of isolated stroma and epithelium from rat ventral prostate during androgen deprivation and estrogen treatment.
    Zhao GQ; Bacher M; Friedrichs B; Schmidt W; Rausch U; Goebel HW; Tuohimaa P; Aumüller G
    Exp Clin Endocrinol; 1993; 101(2):69-77. PubMed ID: 8405142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate specific antigen in the expressed prostatic fluid of men with benign prostatic hyperplasia and prostate carcinoma.
    Kim ED; Smith ND; Grayhack JT
    J Urol; 1995 Nov; 154(5):1802-5. PubMed ID: 7563351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent intraprostatic androgen concentrations after medical castration in healthy men.
    Page ST; Lin DW; Mostaghel EA; Hess DL; True LD; Amory JK; Nelson PS; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3850-6. PubMed ID: 16882745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue prostate-specific antigen and androgen receptor immunoreactivity in prostate cancer biopsies before, during and after neo-adjuvant androgen deprivation followed by radiotherapy.
    Ogreid P; Berner A; Dahl O; Rettedal E; Fosså SD
    Eur Urol; 1999 Aug; 36(2):116-22. PubMed ID: 10420032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of changes in prostate-specific markers after endocrine treatment of stage D2 prostatic cancer.
    Matzkin H; Eber P; Todd B; van der Zwaag R; Soloway MS
    Cancer; 1992 Nov; 70(9):2302-9. PubMed ID: 1382828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.